DUBLIN, Aug. 6, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Metabolomics Market by Technique, Application & by Indication - Global Forecast to 2019" report to their offering.
In this report, the global metabolomics market is segmented based on techniques, applications, indications, and geography. Based on techniques, the metabolomics market is classified into Gas Chromatography, High Performance Liquid Chromatography (HPLC), Ultra Performance Liquid Chromatography (UPLC), Nuclear Magnetic Resonance Spectroscopy (NMR), Mass Spectrometry (MS), and Surface-based Mass Analysis.
The application market covers biomarker discovery, drug discovery/drug assessment, toxicology testing, nutrigenomics, and others. This report also discusses the key market drivers, restraints, and opportunities in the global metabolomics market and its sub-markets.
The global metabolomics market is expected to grow at a strong CAGR during the forecast period of 2014 to 2019 and is estimated to be worth $2,100 million by 2019. The market is mainly driven by the increasing research funding for metabolomics from governments and private investors, growing demand for personalized medicine in the U.S. and Europe, and the increasing need for toxicology testing. However, low adoption rates and data complexity inhibit the growth of the market to a certain extent.
During the forecast period, the high performance liquid chromatography (HPLC) segment will continue to drive and dominate the metabolomics market.
Key Topics Covered:
2 Executive Summary
3 Premium Insights
4 Technology Investment Potential
5 Market Overview
6 Market Share Analysis
7 Metabolomics Market, by Technique
8 Metabolomics Market, by Application
9 Metabolomics Market, by Indication
10 Metabolomics Market, by Geography
11 Competitive Landscape
12 Company Profiles
For more information visit http://www.researchandmarkets.com/research/z7r9k3/metabolomics
Media Contact: Laura Wood, +353-1-481-1716, email@example.com
|SOURCE Research and Markets|
Copyright©2014 PR Newswire.
All rights reserved